Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Auxora for Critical COVID-19 Pneumonia
NCT05171920Phase 2Withdrawn
- Sponsor
- CalciMedica
- Start
- Jan 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Auxora in COVID-19 pneumonia, sponsored by CalciMedica. Planned start Jan 2022; status: withdrawn.
02
Drugs
Auxora
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT05171920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05171920.